PharMatrix owns proprietary rights to industry tools that expose PBM “spread pricing” techniques that cost plan sponsors billions of dollars each year.

PharMatrix exposes formulary manipulation and other industry techniques designed to maximize financial returns to the PBM at the expense of the plan sponsor and their members.